Searched for: in-biosketch:true
person:marmac01
Increased circulating blood cell counts in combat-related PTSD: Associations with inflammation and PTSD severity
Lindqvist, Daniel; Mellon, Synthia H; Dhabhar, Firdaus S; Yehuda, Rachel; Grenon, S Marlene; Flory, Janine D; Bierer, Linda M; Abu-Amara, Duna; Coy, Michelle; Makotkine, Iouri; Reus, Victor I; Aschbacher, Kirstin; Bersani, F Saverio; Marmar, Charles R; Wolkowitz, Owen M
Inflammation is reported in post-traumatic stress disorder (PTSD). Few studies have investigated circulating blood cells that may contribute to inflammation. We assessed circulating platelets, white blood cells (WBC) and red blood cells (RBC) in PTSD and assessed their relationship to inflammation and symptom severity. One-hundred and sixty-three male combat-exposed veterans (82 PTSD, 81 non-PTSD) had blood assessed for platelets, WBC, and RBC. Data were correlated with symptom severity and inflammation. All cell counts were significantly elevated in PTSD. There were small mediation effects of BMI and smoking on these relationships. After adjusting for these, the differences in WBC and RBC remained significant, while platelet count was at trend level. In all subjects, all of the cell counts correlated significantly with inflammation. Platelet count correlated with inflammation only in the PTSD subjects. Platelet count, but none of the other cell counts, was directly correlated with PTSD severity ratings in the PTSD group. Combat PTSD is associated with elevations in RBC, WBC, and platelets. Dysregulation of all three major lineages of hematopoietic cells in PTSD, as well as their significant correlation with inflammation, suggest clinical significance of these changes.
PMID: 28942957
ISSN: 1872-7123
CID: 3068982
Emotion and symptom-focused engagement (EASE): an intervention for individuals with acute leukemia (AL) [Meeting Abstract]
Rodin, Gary; Malfitano, Carmine; Rydall, Anne; Lo, Christopher; Schimmer, Aaron; Marmar, Charles; Zimmermann, Camilla
ISI:000407688900052
ISSN: 1099-1611
CID: 2676962
Biological predictors of insulin resistance associated with posttraumatic stress disorder in young military veterans
Blessing, Esther M; Reus, Victor; Mellon, Synthia H; Wolkowitz, Owen M; Flory, Janine D; Bierer, Linda; Lindqvist, Daniel; Dhabhar, Firdaus; Li, Meng; Qian, Meng; Abu-Amara, Duna; Galatzer-Levy, Isaac; Yehuda, Rachel; Marmar, Charles R
Posttraumatic stress disorder (PTSD) is associated with increased risk for Type 2 diabetes and cardiovascular disease (cardiometabolic disease), warranting research into targeted prevention strategies. In the present case-control study of 160 young (mean age 32.7 years) male military veterans, we aimed to assess whether PTSD status predicted increased markers of cardiometabolic risk in otherwise healthy individuals, and further, to explore biological pathways between PTSD and these increased markers of cardiometabolic risk. Toward these aims, we compared measures of cardiometabolic risk, namely insulin resistance (IR) (HOMA-IR), metabolic syndrome (MetS) and prediabetes, between 80 PTSD cases and 80 controls without PTSD. We then determined whether PTSD-associated increases in HOMA-IR were correlated with select biological variables from pathways previously hypothesized to link PTSD with cardiometabolic risk, including systemic inflammation (increased C-reactive protein, interleukin-6, and tumor necrosis factor alpha), sympathetic over-activity (increased resting heart rate), and neuroendocrine dysregulation (increased plasma cortisol or serum brain-derived neurotrophic factor (BDNF)). We found PTSD diagnosis was associated with substantially higher HOMA-IR (cases 4.3+/-4.3 vs controls 2.4+/-2.0; p<0.001), and a higher frequency of MetS (cases 21.3% vs controls 2.5%; p<0.001), but not prediabetes (cases 20.0% vs controls 18.8%; p>0.05). Cases also had increased pro-inflammatory cytokines (p<0.01), heart rate (p<0.001), and BDNF (p<0.001), which together predicted increased HOMA-IR (adjusted R2=0.68, p<0.001). Results show PTSD diagnosis in young male military veterans without cardiometabolic disease is associated with increased IR, predicted by biological alterations previously hypothesized to link PTSD to increased cardiometabolic risk. Findings support further research into early, targeted prevention of cardiometabolic disease in individuals with PTSD.
PMID: 28521179
ISSN: 1873-3360
CID: 2563012
Predictors of PTSD 40 years after combat: Findings from the National Vietnam Veterans longitudinal study
Steenkamp, Maria M; Schlenger, William E; Corry, Nida; Henn-Haase, Clare; Qian, Meng; Li, Meng; Horesh, Danny; Karstoft, Karen-Inge; Williams, Christianna; Ho, Chia-Lin; Shalev, Arieh; Kulka, Richard; Marmar, Charles
BACKGROUND: Few studies have longitudinally examined predictors of posttraumatic stress disorder (PTSD) in a nationally representative sample of US veterans. We examined predictors of warzone-related PTSD over a 25-year span using data from the National Vietnam Veterans Longitudinal Study (NVVLS). METHODS: The NVVLS is a follow-up study of Vietnam theater veterans (N = 699) previously assessed in the National Vietnam Veterans Readjustment Study (NVVRS), a large national-probability study conducted in the late 1980s. We examined the ability of 22 premilitary, warzone, and postmilitary variables to predict current warzone-related PTSD symptom severity and PTSD symptom change in male theater veterans participating in the NVVLS. Data included a self-report Health Questionnaire survey and a computer-assisted telephone Health Interview Survey. Primary outcomes were self-reported PTSD symptoms assessed by the PTSD Checklist for DSM-5 (PCL 5) and Mississippi PTSD Scale (M-PTSD). RESULTS: Predictors of current PTSD symptoms most robust in hierarchical multivariable models were African-American race, lower education level, negative homecoming reception, lower current social support, and greater past-year stress. PTSD symptoms remained largely stable over time, and symptom exacerbation was predicted by African-American race, lower education level, younger age at entry into Vietnam, greater combat exposure, lower current social support, and greater past-year stressors. CONCLUSIONS: Findings confirm the robustness of a select set of risk factors for warzone-related PTSD, establishing that these factors can predict PTSD symptom severity and symptom change up to 40 years postdeployment.
PMID: 28489300
ISSN: 1520-6394
CID: 2549032
Whole-genome DNA methylation status associated with clinical PTSD measures of OIF/OEF veterans
Hammamieh, R; Chakraborty, N; Gautam, A; Muhie, S; Yang, R; Donohue, D; Kumar, R; Daigle, B J Jr; Zhang, Y; Amara, D A; Miller, S-A; Srinivasan, S; Flory, J; Yehuda, R; Petzold, L; Wolkowitz, O M; Mellon, S H; Hood, L; Doyle, F J 3rd; Marmar, C; Jett, M
Emerging knowledge suggests that post-traumatic stress disorder (PTSD) pathophysiology is linked to the patients' epigenetic changes, but comprehensive studies examining genome-wide methylation have not been performed. In this study, we examined genome-wide DNA methylation in peripheral whole blood in combat veterans with and without PTSD to ascertain differentially methylated probes. Discovery was initially made in a training sample comprising 48 male Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) veterans with PTSD and 51 age/ethnicity/gender-matched combat-exposed PTSD-negative controls. Agilent whole-genome array detected ~5600 differentially methylated CpG islands (CpGI) annotated to ~2800 differently methylated genes (DMGs). The majority (84.5%) of these CpGIs were hypermethylated in the PTSD cases. Functional analysis was performed using the DMGs encoding the promoter-bound CpGIs to identify networks related to PTSD. The identified networks were further validated by an independent test set comprising 31 PTSD+/29 PTSD- veterans. Targeted bisulfite sequencing was also used to confirm the methylation status of 20 DMGs shown to be highly perturbed in the training set. To improve the statistical power and mitigate the assay bias and batch effects, a union set combining both training and test set was assayed using a different platform from Illumina. The pathways curated from this analysis confirmed 65% of the pool of pathways mined from training and test sets. The results highlight the importance of assay methodology and use of independent samples for discovery and validation of differentially methylated genes mined from whole blood. Nonetheless, the current study demonstrates that several important epigenetically altered networks may distinguish combat-exposed veterans with and without PTSD.
PMCID:5538114
PMID: 28696412
ISSN: 2158-3188
CID: 2630272
Basal forebrain mediated increase in brain CRF is associated with increased cholinergic tone and depression
Gollan, Jackie K; Dong, Hongxin; Bruno, Davide; Nierenberg, Jay; Nobrega, Jose N; Grothe, Michel J; Pollock, Bruce G; Marmar, Charles R; Teipel, Stefan; Csernansky, John G; Pomara, Nunzio
PMID: 28477491
ISSN: 1872-7123
CID: 2548752
Post-Traumatic Stress Disorder
Shalev, Arieh; Liberzon, Israel; Marmar, Charles
PMID: 28636846
ISSN: 1533-4406
CID: 2603942
Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study
Hashimoto, Kenji; Ishima, Tamaki; Sato, Yasunori; Bruno, Davide; Nierenberg, Jay; Marmar, Charles R; Zetterberg, Henrik; Blennow, Kaj; Pomara, Nunzio
Major depressive disorder (MDD) in the elderly is a risk factor for dementia, but the precise biological basis remains unknown, hampering the search for novel biomarkers and treatments. In this study, we performed metabolomics analysis of cerebrospinal fluid (CSF) from cognitively intact elderly patients (N = 28) with MDD and age- and gender-matched healthy controls (N = 18). The CSF levels of 177 substances were measured, while 288 substances were below the detection limit. Only ascorbic acid was significantly different, with higher levels in the MDD group at baseline. There were no correlations between CSF ascorbic acid levels and clinical variables in MDD patients at baseline. At the 3-year follow-up, there was no difference of CSF ascorbic acid levels between the two groups. There was a negative correlation between CSF ascorbic acid and CSF amyloid-beta42 levels in all subjects. However, there were no correlations between ascorbic acid and other biomarkers (e.g., amyloid-beta40, total and phosphorylated tau protein). This preliminary study suggests that abnormalities in the transport and/or release of ascorbic acid might play a role in the pathogenesis of late-life depression.
PMCID:5471282
PMID: 28615661
ISSN: 2045-2322
CID: 2593722
Multidimensional Network-Clusters to Elucidate PTSD Biology: An Epigenomic Study of OEF/OIF Cohort [Meeting Abstract]
Chakraborty, Nabarun; Hammamieh, Rasha; Yang, Ruoting; Gautam, Aarti; Muhie, Seid; Abu Amara, Duna; Marmar, Charles; Jett, Marti
ISI:000400348700705
ISSN: 1873-2402
CID: 2576902
Failure to Downregulate Amygdala Activation during Regulation of Emotional Conflict in Post Traumatic Stress Disorder: Results from a Large Veteran Sample [Meeting Abstract]
Chick, Christina; de los Angeles, Carlo; Patenaude, Brian; Longwell, Parker; Shpigel, Emmanuel; Gonzalez, Bryan; Durkin, Kathleen; Chen, Jingyun; Abu Amara, Duna; Hart, Roland; Mann, Silas; Maron-Katz, Adi; Marmar, Charles; Etkin, Amit
ISI:000400348700470
ISSN: 1873-2402
CID: 2576882